IFNA1 and type 1 diabetes mellitus: Altogether our data demonstrate the differential immune visibility of beta cells in the early and late phases of disease progression in type 1 diabetes and illustrate how IFNɣ can accelerate beta cell destruction by changing the composition of the immunoproteasome.